Skip to Main Content

Paper Details

Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
Am J Hematol
30
2022
Author NameAffiliation
Guillermo Garcia-ManeroThe University of Texas MD Anderson Cancer Center
Farhad RavandiThe University of Texas MD Anderson Cancer Center
Jorge CortesThe University of Texas MD Anderson Cancer Center
Gautam BorthakurThe University of Texas MD Anderson Cancer Center
Courtney D DiNardoThe University of Texas MD Anderson Cancer Center
Hagop KantarjianThe University of Texas MD Anderson Cancer Center
  • 1 - 6

Datasets

Release 1.2